Abstract: The invention provides novel compounds, pharmaceutical compositions and methods of preparation and use thereof for treating disease affecting the central nervous system such as multiple sclerosis.
Type:
Grant
Filed:
May 23, 2022
Date of Patent:
September 17, 2024
Assignees:
GLOBE BIOMEDICAL CO., LTD., GLOBE HEALTH INSTITUTE LLC